Does ERDAFITINIB Cause Off label use? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Off label use have been filed in association with ERDAFITINIB (BALVERSA). This represents 7.8% of all adverse event reports for ERDAFITINIB.
86
Reports of Off label use with ERDAFITINIB
7.8%
of all ERDAFITINIB reports
5
Deaths
16
Hospitalizations
How Dangerous Is Off label use From ERDAFITINIB?
Of the 86 reports, 5 (5.8%) resulted in death, 16 (18.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERDAFITINIB. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does ERDAFITINIB Cause?
Death (255)
Diarrhoea (75)
Stomatitis (58)
Fatigue (45)
Onycholysis (44)
Disease progression (41)
Dry mouth (41)
Nail disorder (40)
Hyperphosphataemia (39)
Dry eye (38)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ERDAFITINIB Alternatives Have Lower Off label use Risk?
ERDAFITINIB vs ERENUMAB
ERDAFITINIB vs ERENUMAB-AOOE
ERDAFITINIB vs ERENUMAB\ERENUMAB-AOOE
ERDAFITINIB vs ERGOCALCIFEROL
ERDAFITINIB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL